Clinical trial
Measurement Of Serum Levels Of Two Antiepileptic Drugs During Conversion In…
NCT00043914 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00043914 |
|---|---|
| Title | Measurement Of Serum Levels Of Two Antiepileptic Drugs During Conversion In Patients With Epilepsy |
| Official title | A Multicenter, Open-Label Conversion of Valproate Monotherapy to Lamotrigine Monotherapy in Patients With Epilepsy |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Epilepsy |
| Intervention type | Drug |
| Interventions | lamotrigine |
| Enrollment | 72 |
| Start date | Jan 14, 2002 |
| Primary completion | Jan 29, 2003 |
| Completion | Jan 29, 2003 |
| First posted | Aug 16, 2002 |
| Last update posted | Oct 9, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: